A novel role for an established player: anemia drug erythropoietin for the treatment of cerebral hypoxia/ischemia
- 1 August 2004
- journal article
- review article
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 31 (1) , 39-44
- https://doi.org/10.1016/j.transci.2004.05.001
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Expression patterns of erythropoietin and its receptor in the developing midbrainBrain Structure and Function, 2004
- Erythropoietin: a candidate compound for neuroprotection in schizophreniaMolecular Psychiatry, 2003
- Erythropoietin Selectively Attenuates Cytokine Production and Inflammation in Cerebral Ischemia by Targeting Neuronal ApoptosisThe Journal of Experimental Medicine, 2003
- Ischemic tolerance and endogenous neuroprotectionTrends in Neurosciences, 2003
- Erythropoietin Receptor-mediated Inhibition of Exocytotic Glutamate Release Confers Neuroprotection during Chemical IschemiaPublished by Elsevier ,2001
- Survival of hippocampal neurons in culture upon hypoxiaNeuroReport, 2000
- Selfotel in Acute Ischemic StrokeStroke, 2000
- A Potential Role for Erythropoietin in Focal Permanent Cerebral Ischemia in MiceJournal of Cerebral Blood Flow & Metabolism, 1999
- Cytokine receptor signallingNature, 1995
- Neurotrophic effect of hematopoietic cytokines on cholinergic and other neurons in vitroInternational Journal of Developmental Neuroscience, 1995